A new paper published on the preprint server medRxiv in April 2020 shows that the use of the already approved drug ivermectin in clinical trials to treat severe acute respiratory syndrome coronavirus ...
A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University has expanded its testing platform to evaluate ivermectin at a higher dose for a longer period of ...
A Houston doctor says he is using the anti-parasite medication ivermectin with a combination of drugs to treat COVID-19 patients, despite warnings from federal health officials that it could cause ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results